What is NanoImaging Services?
NanoImaging Services operates as a specialized CRO, providing critical cryo-electron microscopy (cryo-EM) solutions to pharmaceutical and biotechnology firms. Their service portfolio encompasses structural biology, nanoparticle characterization, and GMP-compliant imaging, leveraging in-house advanced microscopy equipment. The company recently bolstered its capabilities and market position through the strategic acquisition of Proteos, a recognized leader in protein production CRO services. This expansion is designed to offer a more integrated approach to drug development, from protein generation to high-resolution imaging.
How much funding has NanoImaging Services raised?
NanoImaging Services has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for NanoImaging Services?
With its substantial backing and recent strategic acquisition, NanoImaging Services is poised for accelerated expansion and enhanced service delivery. The company's focus on late-stage funding suggests a mature operational phase, likely geared towards scaling its cryo-EM infrastructure, expanding its client base within the global pharmaceutical and biotech industries, and potentially integrating its newly acquired protein production capabilities more deeply into its service offerings. Continued investment in cutting-edge imaging technology and talent acquisition will be crucial for NIS to maintain its competitive edge and solidify its role as a key partner in the drug discovery pipeline.
See full NanoImaging Services company page
